Major mediator of cancer-related inflammation via NFkB activation; regulation of the expression of metastatic promoting genes in ER positive BCCs (see Table 1A, TAMs); induced E2 production in TME; autocrine loop in ER+BCCs sustained by increased TNalpha-E2 production. Here, NFKB1 is linked to cancer.